Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 14, 2015; 21(10): 3020-3029
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.3020
Table 1 Baseline clinical and laboratory characteristics of study population
All patients (n = 40)CP A (n = 18)CP B (n = 10)CP C (n = 12)P value1
Sex (M/F), n (%)35/5 (87.5/12.5)16/2 (88.9/11.1)9/1 (90/10)10/2 (83.3/16.7)0.870
Age, median years (range)59 (37-75)59.5 (43-75)60.5 (37-71)59 (45-70)0.838
Smoking, n (%)15 (37.5)7 (38.9)3 (30)5 (41.7)0.954
HCC, n (%)5 (12.5)1 (5.6)1 (10)3 (25)0.277
Hemoglobin (11.8-17 g/dL)12.35 (9.3-16.6)14.3 (9.8-16.6)12.75 (10.2-15.1)10.1 (9.3-13.2)0.002
WBC count (4 × 109/L-11 × 109/L)5.888 (3.2-15.18)6.66 (3.2-12.97)5.31 (4.1-8.97)5.66 (4.15-15.18)0.093
Platelet count (150 × 109/L-400 × 109/L)113 (81-246)148 (87-246)117.5 (70-198)127 (75-218)0.306
INR (1-1.3)1.28 (0.87-2.32)1.09 (0.87-1.59)1.2 (1.07-1.92)1.58 (1.24-2.32)0.001
PT (s)15.25 (9.8-24.8)11.9 (9.8-18.3)15.15 (12.2-17)18.6 (15.2-24.8)< 0.001
Total bilirubin (0.1-1.3 mg/dL)1.1 (0.28-8.6)0.72 (0.28-1.19)1.23 (0.85-3.5)2.4 (1.6-8.6)< 0.001
Albumin (3.5-5.5 g/dL)3.65 (0.9-4.6)4 (3.4-4.6)3.6 (2.6-4.3)2.8 (0.9-3.2)< 0.001
Creatinine (0.9-1.6 mg/dL)0.82 (0.68-1.8)0.88 (0.7-1.7)0.82 (0.7-1.4)0.8 (0.68-1.8)0.967
Urea (15-54 mg/dL)28 (16-110)28 (18-64)26.5 (21-47)29 (16-110)0.981
SGOT (5-40 U/L)36 (15-149)32.3 (15-48)59 (24-149)58 (18-128)0.017
SGPT (5-40 U/L)33 (8-156)32 (8-60)46 (23-156)32 (11-64)0.298
ALP (U/L)116 (37-303)104 (41-236)113.5 (75-244)123 (37-303)0.324
GGT (U/L)94 (12-328)82.5 (12-231)135 (61-328)108 (28-199)0.057
Glucose (75-115 mg/dL)99 (60-126)99 (71-126)105 (94-126)92 (60-118)0.170
Serum sodium (134-152 mmol/L)138 (129-146)140.8 (134.5-146)137.4 (135-141)135 (129-142)0.012
Cholesterol (mg/dL)146 (66-341)188.5 (130-341)133 (91-173)146 (66-168)0.041
Triglycerides (mg/dL)88.5 (43-142)106 (43-142)74.5 (47-139)76 (46-116)0.525
Child-Pugh score (range)7 (5-12)NANANANA
MELD score (range)10 (6-25)7 (6-16)11 (8-18)18 (13-25)< 0.001
Ascites, n (%)14 (35)04 (40)10 (83.3)< 0.001
Encephalopathy, n (%)2 (5)1 (5.6)01 (8.3)0.664